Stanniocalicin 2 suppresses breast cancer cell migration and invasion via the PKC/Claudin-1-mediated signaling

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Hou, Jing ^a,b   Wang, Ziliang ^a,b   Xu, Han ^a,b   Yang, Lina ^a,b   Yu, Xiaoli ^a   Yang, Zhaozhi ^a   Deng, Yun ^a,b   Meng, Jiao ^a,b   Feng, Yan ^a   Guo, Xiaomao ^a   Yang, Gong ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 1; COMPLEMENTARY DNA; GELATINASE B; GLYCOPROTEIN; PROTEIN KINASE C; PROTEIN ZO1; SHORT HAIRPIN RNA; STANNIOCALICIN; STANNIOCALICIN 2; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG; CLDN1 PROTEIN, HUMAN; SIGNAL PEPTIDE; STC2 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; BREAST METASTASIS; CANCER INHIBITION; CARCINOGENESIS; CELL CLONING; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL STRUCTURE; COLONY FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REPRESSION; EPITHELIAL MESENCHYMAL TRANSITION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPINDLE CELL; TUMOR VOLUME; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; CANCER TRANSPLANTATION; CELL MOTION; FEMALE; LUNG TUMOR; LYMPH NODE METASTASIS; MCF-7 CELL LINE; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; SECONDARY; TUMOR INVASION;

ANIMALIA;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; CLAUDIN-1; FEMALE; GLYCOPROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MCF-7 CELLS; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PROTEIN KINASE C; SIGNAL TRANSDUCTION;

EID: 84926647837     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122179     Document Type: Article

References (41)

1. Wagner GF, Vozzolo BL, Jaworski E, Haddad M, Kline RL, et al. (1997) Human stanniocalcin inhibits renal phosphate excretion in the rat. J Bone Miner Res 12:165-171. PMID: 9041047
2. Madsen KL, Tavernini MM, Yachimec C, Mendrick DL, Alfonso PJ, et al. (1998) Stanniocalcin: a novel protein regulating calcium and phosphate transport across mammalian intestine. Am J Physiol 274:G96-102. PMID: 9458778
3. Wagner GF, Dimattia GE (2006) The stanniocalcin family of proteins. J Exp Zool A Comp Exp Biol 305:769-780. PMID: 16902962
4. Ito D, Walker JR, Thompson CS, Moroz I, Lin W, et al. (2004) Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties. Mol Cell Biol 24:9456-9469. PMID: 15485913
5. Gagliardi AD, Kuo EY, Raulic S, Wagner GF, Di Mattia GE (2005) Human stanniocalcin-2 exhibits potent growth-suppressive properties in transgenic mice independently of growth hormone and IGFs.. Am J Physiol Endocrinol Metab 288:E92-105. PMID: 15367391
6. Volland S, Kugler W, Schweigerer L, Wilting J, Becker J (2009) Stanniocalcin 2 promotes invasion and is associated with metastatic stages in neuroblastoma.. Int J Cancer 125:2049-2057. doi: 10.1002/ijc. 24564 PMID: 19582875
7. Chang AC, Jellinek DA, Reddel RR (2003) Mammalian stanniocalcins and cancer. Endocr Relat Cancer 10:359-373. PMID: 14503913
8. Law AY, Lai KP, Ip CK, Wong AS, Wagner GF, et al. (2008) Epigeneticand HIF-1 regulation of stanniocalcin-2 expression in human cancer cells. Exp Cell Res 314:1823-1830. doi: 10.1016/j.yexcr.2008. 03.001 PMID: 18394600
9. Law AY, Wong CK (2010) Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia.. Exp Cell Res 316:466-476. doi: 10.1016/j.yexcr.2009.09.018 PMID: 19786016
10. Tamura K, Furihata M, Chung SY, Uemura M, Yoshioka H, et al. (2009) Stanniocalcin 2overexpression in castration-resistant prostate cancer and aggressive prostate cancer. Cancer Sci 100:914-919. doi: 10.1111/j.1349-7006.2009.01117.x PMID: 19298603
11. Ieta K, Tanaka F, Yokobori T, Kita Y, Haraguchi N, et al. (2009) Clinicopathological significance of stanniocalcin 2 gene expression in colorectal cancer. Int J Cancer 125:926-931. doi: 10.1002/ijc.24453 PMID: 19415750
12. Bouras T, Southey MC, Chang AC, Reddel RR, Willhite D, et al. (2002) Stanniocalcin 2 is an estrogenresponsive gene coexpressed with the estrogen receptor in human breast cancer. Cancer Res 62:1289-1295. PMID: 11888893
13. Zucchi I, Mento E, Kuznetsov VA, Scotti M, Valsecchi V, et al. (2004) Gene expression profiles of epithelial cells microscopically isolated from a breast-invasive ductal carcinoma and a nodal metastasis. Proc Natl Acad Sci U S A 101:18147-18152. PMID: 15608061
14. Iwao K, Matoba R, Ueno N, Ando A, Miyoshi Y, et al. (2002) Molecular classification of primary breast tumors possessing distinct prognostic properties. Hum Mol Genet 11:199-206. PMID: 11809729
15. Yamamura J, Miyoshi Y, Tamaki Y, Taguchi T, Iwao K, et al. (2004) mRNA expression level of estrogen-inducible gene, alpha 1-antichymotrypsin, is a predictor of early tumor recurrence in patients with invasive breast cancers. Cancer Sci 95:887-892. PMID: 15546506
16. Esseghir S, Kennedy A, Seedhar P, Nerurkar A, Poulsom R, et al. (2007) Identification of NTN4, TRA1, and STC2 as prognostic markers in breast cancer in a screen for signal sequence encoding proteins. Clin Cancer Res 13:3164-3173. PMID: 17545519
17. Burgess DJ (2013) Breast cancer: Circulating and dynamic EMT. Nat Rev Cancer 13:148. doi: 10. 1038/nrc3475 PMID: 23407577
18. Williams LV, Veliceasa D, Vinokour E, Volpert OV (2013) miR-200b inhibits prostate cancer EMT, growth and metastasis.. PLoS One 8:e83991. doi: 10.1371/journal.pone.0083991 PMID: 24391862
19. Cowin P, Welch DR (2007) Breast cancer progression: controversies and consensus in the molecular mechanisms of metastasis and EMT.. J Mammary Gland Biol Neoplasia 12:99-102. doi: 10.1007/s10911-007-9041-9 PMID: 18769505
20. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, et al. (2008) A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 9:582-589. doi: 10.1038/embor.2008.74 PMID: 18483486
21. Smit MA, Peeper DS (2008) Deregulating EMT and senescence: double impact by a single twist. Cancer Cell 14:5-7. doi: 10.1016/j.ccr.2008.06.012 PMID: 18598938
22. Ye Y, Xiao Y, Wang W, Yearsley K, Gao JX, et al. (2010) ERalpha signaling through slug regulates E-cadherin and EMT. Oncogene 29:1451-1462. doi: 10.1038/onc.2009.433 PMID: 20101232
23. Ivaska J (2011) Vimentin: Central hub in EMT induction? Small GTPases 2:51-53. PMID: 21686283
24. Lander R, Nordin K, La Bonne C (2011) The F-box protein Ppa is a common regulator of core EMT factors Twist, Snail, Slug, and Sip1.. J Cell Biol 194:17-25. doi: 10.1083/jcb.201012085 PMID: 21727196
25. Wang Y, Shi J, Chai K, Ying X, Zhou BP (2013) The Role of Snail in EMT and Tumorigenesis. Curr Cancer Drug Targets 13:963-972. PMID: 24168186
26. Law AY, Wong CK (2010) Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells.. Exp Cell Res 316:3425-3434. doi: 10.1016/j.yexcr.2010. 06.026 PMID: 20619259
27. Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, et al. (2007) Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Breast Cancer Res 9:R76. PMID: 17980029
28. Yang G, Rosen DG, Zhang Z, Bast RC Jr., Mills GB, et al. (2006) The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc Natl Acad Sci USA 103:16472-16477. PMID: 17060621
29. Yang G, Thompson JA, Fang B, Liu J (2003) Silencing of H-ras gene expression by retrovirus-mediated siRNA decreases transformation efficiency and tumorgrowth in a model of human ovarian cancer.. Oncogene 22:5694-5701. PMID: 12944918
30. Raulic S, Ramos-Valdes Y, Di Mattia GE (2008) Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro.. J Endocrinol 197:517-529. doi: 10. 1677/JOE-08-0043 PMID: 18492817
31. Chang AC, Hook J, Lemckert FA, McDonald MM, Nguyen MA, et al. (2008) The murine stanniocalcin 2 gene is a negative regulator of postnatal growth. Endocrinology 149:2403-2410. doi: 10.1210/en. 2007-1219 PMID: 18258678
32. Joensuu K, Heikkila P, Andersson LC (2008) Tumor dormancy: elevated expression of stanniocalcins in late relapsing breast cancer.. Cancer Lett 265:76-83. doi: 10.1016/j.canlet.2008.02.022 PMID: 18355956
33. Okumura M, Yamamoto M, Sakuma H, Kojima T, Maruyama T, et al. (2002) Leptinand high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-alpha and PPAR expression. BiochimBiophysActa 1592:107-116. PMID: 12379472
34. Yang MY, Hsu LS, Peng CH, Shi YS, Wu CH, et al. (2010) Polyphenol-rich extracts from Solanum nigrum attenuated PKC alpha-mediated migration and invasion of hepatocellular carcinoma cells. J Agric FoodChem 58:5806-5814. doi: 10.1021/jf100718b PMID: 20349911
35. Li Z, Wang N, Fang J, Huang J, Tian F, et al. (2012) Role of PKC-ERK signaling intamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells. Oncol Rep 27:1879-1886. doi: 10. 3892/or.2012.1728 PMID: 22427054
36. Leotlela PD, Wade MS, Duray PH, Rhode MJ, Brown HF, et al. (2007) Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility. Oncogene 26:3846-3856. PMID: 17160014
37. Stebbing J, Filipovic A, Giamas G (2013) Claudin-1 as a promoter of EMTin hepatocellular carcinoma.. Oncogene 32:4871-4872. doi: 10.1038/onc.2012.591 PMID: 23318416
38. French AD, Fiori JL, Camilli TC, Leotlela PD, O'Connell MP, et al. (2009) PKC and PKA phosphorylation affect the subcellular localization of claudin-1 in melanoma cells. Int J Med Sci 6:93-101. PMID: 19305641
39. Gonzalez-Mariscal L, Betanzos A, Nava P, Jaramillo BE (2003) Tight junction proteins. Prog Biophys Mol Biol 81:1-44. PMID: 12475568
40. Zeiger W, Ito D, Swetlik C, Oh-Hora M, Villereal ML, et al. (2011) Stanniocalcin 2 is a negative modulator of store-operated calcium entry. Mol Cell Biol 31:3710-3722. doi: 10.1128/MCB.05140-11 PMID: 21746875
41. Sjo A, Magnusson KE, Peterson KH (2010) Protein kinase C activation has distinct effects on the localization, phosphorylation and detergent solubility of the claudin protein family in tight and leaky epithelial cells.. J MembrBiol 236:181-189. doi: 10.1007/s00232-010-9289-7 PMID: 20697888